Login / Signup

Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.

Pierre MarcantP BalayéR MerhiFatma JendoubiA NosbaumNadia Raison-PeyronA Du-ThanhA LasekM-C Ferrier le BouedecF TetartA ValoisSébastien BarbarotA SoriaMarie JachietD Staumont-Sallénull null
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Keyphrases
  • atopic dermatitis
  • high intensity
  • early onset
  • drug induced